Eflucimibe

Eflucimibe

SCHEMBL8041449

CCCCCCCCCCCCSC(C(=O)Nc1cc(C)c(O)c(C)c1C)c1ccccc1.CCCCCCCCCCCCSC(C)(C)C(=O)Nc1cc(C)c(O)c(C)c1C

nearest known ligand 0.82

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SOAT2 O75908 1/20 0.82
ACAT1 P24752 1/20 0.82
SOAT1 P35610 1/20 0.82
ALDH1A1 P00352 5/20 0.39
CYP2C9 P11712 3/20 0.38
CYP2C19 P33261 3/20 0.38
CYP1A2 P05177 2/20 0.38
CYP3A4 P08684 2/20 0.38
MAPT P10636 6/20 0.35
LMNA P02545 4/20 0.33
PAX8 Q06710 1/20 0.33
KMT2A Q03164 3/20 0.33
MEN1 O00255 2/20 0.33
NPSR1 Q6W5P4 2/20 0.33
NAAA Q02083 2/20 0.33
PLK1 P53350 1/20 0.32
CYP2D6 P10635 2/20 0.32
TSHR P16473 1/20 0.32
CCR2 P41597 1/20 0.32
POLB P06746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Eflucimibe SCHEMBL29427708 0.91 SOAT2 (1.00) SOAT2ACAT1SOAT1ALDH1A1CYP2C9
Eflucimibe SCHEMBL668294 0.91 SOAT2 (1.00) SOAT2ACAT1SOAT1ALDH1A1CYP2C9
Eflucimibe SCHEMBL668292 0.91 SOAT2 (1.00) SOAT2ACAT1SOAT1ALDH1A1CYP2C9
SCHEMBL8041413 0.85 SOAT1 (0.54) SOAT2ACAT1SOAT1ALDH1A1CYP2C9
SCHEMBL8080785 0.84 SOAT2 (0.62) SOAT2ACAT1SOAT1ALDH1A1LMNA
SCHEMBL5900910 0.81 SOAT2 (0.80) SOAT2ACAT1SOAT1ALDH1A1CYP2C9
SCHEMBL5900907 0.81 SOAT2 (0.80) SOAT2ACAT1SOAT1ALDH1A1CYP2C9
SCHEMBL8417193 0.81 SOAT2 (0.73) SOAT2ACAT1SOAT1ALDH1A1LMNA
SCHEMBL8079670 0.80 SOAT1 (0.79) SOAT2ACAT1SOAT1ALDH1A1CYP2C9
SCHEMBL8416087 0.80 SOAT2 (0.78) SOAT2ACAT1SOAT1ALDH1A1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0874812-B1 NOVEL 2,3,5-TRIMETHYL-4-HYDROXY ANILIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTICAL USE THEREOF PF MEDICAMENT (FR) 2000-04-05 EP claimed